Day Traders Tag icon

×
Lars Fruergaard Jørgensen, President and CEO of Novo Nordisk A/S (NYSE:NVO), is set to face tough questions from the U.S. lawmakers regarding the steep prices of the company’s diabetes and weight-loss drugs, including Ozempic and Wegovy. The United States Senate Committee on Health, Education, Labor, and Pensions (HELP) hearing is scheduled for Tuesday, September 24th. Leading the charge is Senator Bernie Sanders, chair of the Senate committee, who has been outspoken about the high cost of these medicines. Also Read: Novo Nordisk Does Not Operate As Drug Cartel, CEO Defends US Pricing Of Ozempic Against Criticism Over High Drug Prices. The President of the United States, Joe Biden, and Sen. Bernie Sanders, the Senate Chairman of the ...


In The news